Minimed Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for Minimed Group (MMED).

Price Target Range — 4 Quarters

Analyst Consensus — 13 Analysts

11Buy

2Hold

Consensus RatingBuy# Analysts13Avg. Consensus PT$25Upside to Avg. PT+41.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	Jefferies	Michael Toomey	Initiate	Hold	$22
Oct 8, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$26→$28
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Equal-Weight	$22
Sep 24, 2026	Truist Securities	Richard Newitter	Initiate	Buy	$29
Sep 3, 2026	Morgan Stanley	Kallum Titchmarsh	PT Raise	Overweight	$19→$21
Sep 2, 2026	Citigroup	Joanne Wuensch	PT Raise	Buy	$23→$26
Sep 2, 2026	Evercore ISI Group	Daniel Markowitz	PT Raise	Outperform	$20→$27
Sep 2, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$22→$26
Sep 2, 2026	UBS	Patrick Wood	PT Raise	Buy	$25→$28
Sep 2, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$21→$26
Sep 2, 2026	B of A Securities	Travis Steed	PT Raise	Buy	$24→$28
Sep 1, 2026	BTIG	Marie Thibault	PT Raise	Buy	$25→$28
Jul 28, 2026	UBS	—	Assumes	Buy	$25
Jun 4, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$26→$22
May 18, 2026	B of A Securities	Travis Steed	PT Cut	Buy	$27→$20
May 12, 2026	Benchmark	Bruce Jackson	Initiate	Buy	$20
Apr 1, 2026	Barclays	Matt Miksic	Initiate	Overweight	$26
Mar 31, 2026	William Blair	Steven Lichtman	Initiate	Outperform	—
Mar 31, 2026	Citigroup	Joanne Wuensch	Initiate	Buy	$23
Mar 31, 2026	Piper Sandler	Matt O'Brien	Initiate	Neutral	$16

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Jefferies Initiates Coverage On Minimed Group with Hold Rating, Announces Price Target of $22

Jefferies analyst Michael Toomey initiates coverage on Minimed Group (NASDAQ:MMED) with a Hold rating and announces Price Target of $22.

Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Minimed Group, Raises Price Target to $28

Mizuho analyst Anthony Petrone maintains Minimed Group (NASDAQ:MMED) with a Outperform and raises the price target from $26 to $28.

Benzinga Newsdesk

PRO
Barclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22

Barclays analyst Christopher Pasquale initiates coverage on Minimed Group (NASDAQ:MMED) with a Equal-Weight rating and announces Price Target of $22.

Benzinga Newsdesk

PRO
Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29

Truist Securities analyst Richard Newitter initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $29.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21

Morgan Stanley analyst Kallum Titchmarsh maintains Minimed Group (NASDAQ:MMED) with a Overweight and raises the price target from $19 to $21.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26

Citigroup analyst Joanne Wuensch maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $23 to $26.

Benzinga Newsdesk

Minimed Group Inc

Minimed Group Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Jefferies Initiates Coverage On Minimed Group with Hold Rating, Announces Price Target of $22

PRO
Mizuho Maintains Outperform on Minimed Group, Raises Price Target to $28

PRO
Barclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22

PRO
Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29

PRO
Morgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21

PRO
Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26

People Also Watch

People Also Watch

Minimed Group Inc

Minimed Group Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJefferies Initiates Coverage On Minimed Group with Hold Rating, Announces Price Target of $22

PROMizuho Maintains Outperform on Minimed Group, Raises Price Target to $28

PROBarclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22

PROTruist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29

PROMorgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21

PROCitigroup Maintains Buy on Minimed Group, Raises Price Target to $26

People Also Watch

People Also Watch

PRO
Jefferies Initiates Coverage On Minimed Group with Hold Rating, Announces Price Target of $22

PRO
Mizuho Maintains Outperform on Minimed Group, Raises Price Target to $28

PRO
Barclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22

PRO
Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29

PRO
Morgan Stanley Maintains Overweight on Minimed Group, Raises Price Target to $21

PRO
Citigroup Maintains Buy on Minimed Group, Raises Price Target to $26